MMV is at #ASTMH25! Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda. See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC

Heading to #ASTMH2025 in Toronto? 🇨🇦 MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC

MMV staff are celebrating #MalariaDayInTheAmericas by joining the Brazilian #MedTrop25 Conference in Belém this week!

Symposium: MMV & partners at #ASTMH2025 📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention Speakers & topics 👉 bit.ly/3KVqVx7

📣 Applications are open! The SAHRI Fellowship (2026–2029), funded by @globalhealthedctp3.bsky.social, supports mid-career scientists in sub-Saharan Africa advancing health research & innovation in infectious diseases. Apply now 👉 bit.ly/4qfTdT6

MMV & Chiang Mai University have launched a qualitative study in Thailand on paediatric formulations of primaquine and tafenoquine for P. vivax #malaria relapse prevention, exploring perceptions around their use with G6PD testing.

Malaria can become deadly within hours. Through SEMA ReACT, MMV & partners are studying rectal artesunate use in remote Zambia & DRC to improve severe #malaria care. Join us at #ASTMH2025 (11 Nov) for a symposium sharing interim results & insights 👉 bit.ly/46Z7ADQ

Diversifying the use of #malaria meds through the deployment of MFT can keep us one step ahead of resistance. MMV & partners recently conducted a feasibility study in Kenya demonstrating that an MFT approach is feasible, with adequate resources 👉 bit.ly/3IVeQYh

Are you subscribed to MMV’s monthly newsletter? Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV 👉 bit.ly/MMVnewsletter

MMV joins the global health community in mourning the passing of our friend & colleague, Prof. Jean Louis Abdourahim Ndiaye. As we honour Prof. Ndiaye’s memory, we extend our deepest condolences to his family, close friends & colleagues around the world: shorturl.at/VSzLG

“Innovation can’t wait; we need to act now,” says MMV CEO Martin Fitchet, in an opinion piece on the urgent need to stop #malaria drug resistance in its tracks. Read it in @devex.com 👉 bit.ly/42UQ8xU

A #malaria resurgence would cost lives and crush economies. A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria. Read it here 👉 bit.ly/48IJ637

Growing research infrastructure, stronger regulatory frameworks & new opportunities for collaboration are shifting Africa’s clinical trial landscape. 👉 See how harnessing Africa’s untapped clinical trial potential can benefit patients & business: bit.ly/4qema1Z

Are you attending #CPHIA2025 in Durban? Join @mmv.org & Malaria Consortium to explore solutions through #innovation, #surveillance & #partnerships to combat the growing threat of antimalarial drug resistance in Africa. RSVP: forms.office.com/pages/respon... #Malaria #HealthSecurity #GlobalHealth

One country’s victory over #malaria can light the way for others. Suriname's path to elimination was forged by combining community engagement, rapid testing & effective treatment – an approach that can inspire strategies in other countries 👉 bit.ly/4q4jK5R

Burundi’s Ministry of Health & @MSF are combining preventive medicines, #vaccines & bed nets to tackle #malaria in the country’s most-affected regions — a powerful three-pronged approach to protect more children. 👉 bit.ly/4nGdZtq

Are we focusing on the most critical levers to end #malaria? Join MMV & @gatesfoundation.bsky.social at #ASTMH2025 to explore how breakthrough tools, smart strategies and endemic country leadership can help end malaria in our lifetime. 📅 Nov 12, 7:00am bit.ly/4356K60

MMV has joined the @who.int Global Clinical Trials Forum – a major step towards more inclusive #malaria research that reflects the people treatments are meant to serve. Learn more 🔗 bit.ly/47myHc6

Scenes from #WHS2025 – where MMV and partners are connecting the dots between #malaria elimination and global health security. 🌍🤝

Ending #malaria could save millions – and generate trillions. A new Malaria No More and Corporate Council on Africa report shows that ending malaria is not just a humanitarian goal, but one of the world’s largest untapped business opportunities: bit.ly/43222pA

#DayOfTheGirl is a reminder that #malaria elimination is only possible if we do what it takes to protect all groups of patients – and build a world where no one’s future can be compromised by a disease that is entirely preventable and treatable. 🌍✨

Yesterday, MMV and Africa CDC invited partners to a workshop in Accra to exchange insights and brainstorm ways to strengthen regional supply chains for #malaria medicines in Africa. Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊

Ghana launches Coartem® Baby – the first #malaria medicine for newborns & infants – as momentum continues to build across Africa. 🌍 8 more countries are set to approve soon. bit.ly/4mPN8da

Africa’s first-ever Phase 3 adaptive platform trial of #malaria treatments in early pregnancy has enrolled its first patient in Mali – a landmark moment for the SAFIRE consortium conducting the trial.  Press release 👉 bit.ly/4hbmURr #SAFIRE4MalariaInPregnancy

Meet the organization built on the values it takes to achieve a malaria-free future – collaboration, innovation, openness and equity. Together, we can end #malaria – will you join us?

At a moment when global health must accelerate progress & deliver innovations to strengthen security, Gates Foundation is committing $912M to The Global Fund to fight #HIV, #TB & #malaria. Read about this pledge & why “we can’t stop at almost” 👉 bit.ly/4nkCfB4

SMC, vector control & vaccines are a powerful trio against #malaria. A new PLOS Health review shows SMC cuts illness & deaths in kids <5 in Africa’s Sahel — but scaling it means tackling logistics, adherence & access in remote areas. 👉bit.ly/46wcCGB

Today, MMV and @deepmirror.bsky.social convened 40+ scientists in Geneva to co-create the dd4gh platform. Together, we’re using AI/ML to accelerate #malaria drug discovery while building a more inclusive global research community. Next stop: Accra. 👉 Read more: bit.ly/46xigrJ

MMV & partners, with support from Global Health Innovative Technology (GHIT) Fund, have launched a Phase 3 trial of a novel triple therapy (TACT) – the first for uncomplicated #malaria – to help tackle drug resistance & protect the efficacy of existing medicines. 👉 bit.ly/4guQL6L

A single dose, a stronger #malaria elimination strategy. 👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj

Are the mosquitoes that transmit #malaria changing with fluctuating climate conditions? A new @itmantwerp.bsky.social study shows warmer, variable conditions can “reprogram” mosquito biology, making them more resilient & altering transmission patterns 👉 bit.ly/46xVmBH

In @telegraphnews.bsky.social, Dr Ibrahima Socé Fall argues that tackling #malaria, #dengue & #TB is key to saving lives today and preparing for future outbreaks of pandemic potential. 👉 bit.ly/3I4hcU0

For the 4th year in a row, MMV is a ‘very high performer’ in the Global Health 50/50 report. Gender equity drives better science, stronger partnerships and impact in #malaria elimination, and it’s essential to global health security. Learn more 👉 bit.ly/4glIWAb

📢 The Big Push Against Malaria is accelerating global progress towards eradication. On the sidelines, the SMC Alliance — including MMV — is reaffirming the crucial role of seasonal #malaria chemoprevention in protecting children during peak seasons 👉 bit.ly/4ngUhUr

Each addition to the #malaria prevention toolbox advances the elimination agenda. Last month, @who.int recommended spatial emanators, the 1st new vector control product in +40 years. Here's how spatial emanators can help prevent deadly mosquito bites: bit.ly/4njHRLQ

Partial resistance to artemisinin threatens #malaria treatments (ACTs) and risks undoing decades of progress. A new @thelancetinfdis.bsky.social study shows how diversifying ACT use in endemic countries could protect efficacy & buy time for next-gen drugs. 👉 bit.ly/41yFRH1

This Wednesday, @path.org will host a webinar on expanding the impact of #malaria chemoprevention. Join to learn about implementation experiences & how to deliver these prevention tools more widely & equitably. Register here 👉 bit.ly/3UZRDXa

Africa is facing a perfect storm against #malaria, including drug resistance, critical funding gaps & climate change. At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv

#TICAD9 concluded with the Yokohama Declaration, reinforcing Japan-Africa collaboration for development & stability. Civil society advocates have responded with a statement supporting stronger health security & sustainable development in Africa: bit.ly/46ouEun

The authorization of the first-ever #malaria treatment for newborns & young infants represents a major step towards closing a decades-long gap in paediatric malaria care. But why did it take so long to achieve this milestone? @scidevnet.bsky.social investigates: bit.ly/47Y94Px

The 6th PAVE LATAM meeting in Lima gathered partners to align science & policy for relapsing vivax #malaria elimination. From new treatments to cross-border collaboration, momentum is growing. MMV is proud to co-lead this effort with @path.org. Stay tuned for highlights!

Behind every breakthrough is a dedicated face in the lab Meet the scientists & technicians @lshtm.bsky.social & @mrcunitgambia.bsky.social working to understand 🦟 & fight malaria, dengue, Zika, & more. This #WorldMosquitoDay2025, let’s shine a light on their vital work. 👉 bit.ly/45qtn6F

With 14,000 mosquitoes for every human on the planet, we need to level the playing field in the fight against diseases they spread. PDPs like MMV & @dndi.org work across the global health community to deliver new tools & ensure access where they’re needed most. #WorldMosquitoDay

🚀 Imagine a world where #malaria is a thing of the past. With next-gen medicines, innovative #vaccines & smart vector control combined, we’ll be one step closer. Join us this #WorldMosquitoDay in combating malaria, a disease spread by the world’s most dangerous animal.

Recent studies are exploring how genetic tools can interrupt #malaria transmission at different biological stages – from modifying mosquitoes to block parasite development, to reducing their ability to pass it on. Learn more about this research: bit.ly/4olRomL

💊 Resistance to life-saving #malaria medicines threatens 2 decades of progress against the disease. In response, MMV and partners are accelerating #innovation, development and access to next-generation antimalarials with high barriers to resistance: bit.ly/3Zso5ow

Malaria doesn’t have to be deadly to be devastating. In young children, even asymptomatic infections can derail growth. A new study from Malawi links asymptomatic #malaria to poorer nutrition & development in infants. Read more in @springer.springernature.com: bit.ly/3UdYewM

Heading to #TICAD9? MMV, Nagasaki University & Shionogi Inc. are hosting a side event next Friday to explore the relationship between global health & economic development, & Japan's role in building a healthier, more prosperous world for all. 👉 Register: bit.ly/4muX3oO

Kenya's MoH, @malarianomore.org & the Kenya Medical Research Institute will monitor antimalarial drug resistance & study the effectiveness of mosquito ceiling nets to inform policy & prevention initiatives in the country, where 70% of the population is at risk of #malaria: bit.ly/4fmm1o1

On the International Day of the World’s Indigenous Peoples, we’re highlighting the importance of equitable access to care in countries like Brazil, where #malaria elimination depends on ensuring that Indigenous populations are not left behind 🎥 bit.ly/4fxQhfN